Fidelity Investments
EXAS

Fidelity Investments’s Exact Sciences EXAS Stock Holding History

Fidelity Investments’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,154,568
Closed -$117M – 5468
2025
Q4 		$117M Sell
1,154,568
-17,495,813
-94% -$1.41B 0.01% 1103
2025
Q3 		$1.02B Sell
18,650,381
-8,241,935
-31% -$412M 0.05% 283
2025
Q2 		$1.43B Sell
26,892,316
-831,230
-3% -$42.2M 0.08% 205
2025
Q1 		$1.2B Buy
27,723,546
+6,970,041
+34% +$353M 0.08% 220
2024
Q4 		$1.17B Sell
20,753,505
-894,962
-4% -$55.7M 0.07% 225
2024
Q3 		$1.47B Buy
21,648,467
+8,024,431
+59% +$453M 0.09% 180
2024
Q2 		$576M Buy
13,624,036
+12,289,110
+921% +$676M 0.04% 394
2024
Q1 		$92.2M Buy
1,334,926
+452,200
+51% +$28.6M 0.01% 1091
2023
Q4 		$65.3M Sell
882,726
-2,149,302
-71% -$141M 0.01% 1182
2023
Q3 		$207M Sell
3,032,028
-65,935
-2% -$5.59M 0.02% 686
2023
Q2 		$291M Buy
3,097,963
+246,908
+9% +$19.3M 0.02% 581
2023
Q1 		$193M Buy
2,851,055
+2,642,288
+1,266% +$170M 0.02% 717
2022
Q4 		$10.3M Buy
208,767
+46,992
+29% +$1.92M ﹤0.01% 1872
2022
Q3 		$5.26M Buy
161,775
+91,616
+131% +$3.78M ﹤0.01% 2157
2022
Q2 		$2.76M Sell
70,159
-7,360
-9% -$394K ﹤0.01% 2404
2022
Q1 		$5.42M Sell
77,519
-246,176
-76% -$18M ﹤0.01% 2347
2021
Q4 		$25.2M Sell
323,695
-577,695
-64% -$51M ﹤0.01% 1715
2021
Q3 		$86M Sell
901,390
-26,155
-3% -$2.76M 0.01% 1172
2021
Q2 		$115M Sell
927,545
-39,223
-4% -$4.68M 0.01% 1068
2021
Q1 		$127M Sell
966,768
-375,604
-28% -$51.4M 0.01% 966
2020
Q4 		$178M Buy
1,342,372
+372,915
+38% +$45.1M 0.02% 791
2020
Q3 		$98.8M Sell
969,457
-326,742
-25% -$28.2M 0.01% 910
2020
Q2 		$113M Sell
1,296,199
-295,860
-19% -$23.6M 0.01% 830
2020
Q1 		$92.3M Sell
1,592,059
-265,605
-14% -$21.6M 0.01% 788
2019
Q4 		$172M Sell
1,857,664
-58,738
-3% -$5.16M 0.02% 709
2019
Q3 		$173M Sell
1,916,402
-1,519,587
-44% -$173M 0.02% 673
2019
Q2 		$406M Sell
3,435,989
-528,120
-13% -$53.2M 0.05% 384
2019
Q1 		$343M Buy
3,964,109
+417,057
+12% +$35.5M 0.04% 431
2018
Q4 		$224M Buy
3,547,052
+749,223
+27% +$51.4M 0.03% 553
2018
Q3 		$221M Buy
2,797,829
+551,147
+25% +$35.9M 0.02% 635
2018
Q2 		$134M Sell
2,246,682
-1,800
-0.1% -$96.9K 0.02% 817
2018
Q1 		$90.7M Sell
2,248,482
-613,955
-21% -$29.9M 0.01% 1028
2017
Q4 		$150M Buy
2,862,437
+411,404
+17% +$22M 0.02% 805
2017
Q3 		$115M Buy
2,451,033
+132,764
+6% +$5.34M 0.01% 903
2017
Q2 		$82M Buy
2,318,269
+571,796
+33% +$17.6M 0.01% 1074
2017
Q1 		$41.3M Buy
1,746,473
+13,420
+0.8% +$266K 0.01% 1401
2016
Q4 		$23.2M Sell
1,733,053
-501,827
-22% -$8.1M ﹤0.01% 1620
2016
Q3 		$41.5M Sell
2,234,880
-149,481
-6% -$2.63M 0.01% 1376
2016
Q2 		$29.2M Hold
2,384,361
– – ﹤0.01% 1506
2016
Q1 		$16.1M Sell
2,384,361
-238,400
-9% -$1.53M ﹤0.01% 1779
2015
Q4 		$24.2M Hold
2,622,761
– – ﹤0.01% 1599
2015
Q3 		$47.2M Sell
2,622,761
-2,338,949
-47% -$53.7M 0.01% 1271
2015
Q2 		$148M Sell
4,961,710
-1,182,374
-19% -$29.7M 0.02% 848
2015
Q1 		$135M Buy
6,144,084
+574,100
+10% +$14.6M 0.02% 893
2014
Q4 		$153M Buy
5,569,984
+2,947,223
+112% +$71.7M 0.02% 797
2014
Q3 		$50.8M Buy
2,622,761
+609,595
+30% +$11.2M 0.01% 1301
2014
Q2 		$34.3M Buy
2,013,166
+422,705
+27% +$5.82M ﹤0.01% 1533
2014
Q1 		$22.5M Hold
1,590,461
– – ﹤0.01% 1697
2013
Q4 		$18.6M Hold
1,590,461
– – ﹤0.01% 1738
2013
Q3 		$18.8M Buy
1,590,461
+833,500
+110% +$10.7M ﹤0.01% 1712
2013
Q2 		$10.5M Buy
+756,961
New +$8.22M ﹤0.01% 1912

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Fidelity Investments's EXAS Position: Q1 2026 in Review

Fidelity Investments sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,154,568 shares — an estimated $117M sold.

Fidelity Investments first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $1.47B in Q3 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Fidelity Investments reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Fidelity Investments sold 1,154,568 Exact Sciences shares in Q1 2026, an estimated $117M.
  • Fidelity Investments first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • Fidelity Investments's Exact Sciences position peaked at $1.47B in Q3 2024.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.